OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Cancer Research and Clinical Oncology is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Clinical characteristics and long-term outcomes of rhabdomyosarcoma in Korean children, adolescents and young adults: a single-center experience	150
A case of rare metachronous four primary carcinoma	116
Comment on “Predicting metastasis at initial diagnosis and radiotherapy effectiveness in patients with metastatic osteosarcoma”	96
Introducing a standardized assessment of patients’ interest in and usage of CAM in routine cancer care: chances and risks from patients’ and physicians’ point of view	89
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort	89
Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection	79
Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany	76
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma	75
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors	74
Oral microbiota may predict the presence of esophageal squamous cell carcinoma	73
High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients	65
Oncological outcomes of squamous cell carcinoma of the cervical esophagus treated with definitive (chemo‑)radiotherapy: a systematic review and meta‑analysis. In regard to De Virgilio et al	58
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3	58
Relevance of tumor boards for the inclusion of patients in oncological clinical trials	57
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ	56
Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC	56
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells	54
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours	50
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy	50
Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma	47
Comparison of robotic‑assisted versus conventional laparoscopic surgery for mid–low rectal cancer: a systematic review and meta-analysis	45
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma	44
Heterodimerization of cholecystokinin 1 and cholecystokinin 2 receptors in gallbladder cancer: a new mechanism for carcinogenesis	44
MET overexpression in EGFR L858R mutant treatment-naïve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study	43
Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case rep	42

Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy	42
Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies	41
Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas	40
A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection	39
Systematic analysis of mistletoe prescriptions in clinical studies	38
Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer	38
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma	37
Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study	37
Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis	36
Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study	35
Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma	35
Performance of endobronchial ultrasound transbronchial needle aspiration as the first nodal staging procedure for the determination of programmed death ligand-1 expression in non-small cell lung cance	35